Invesco
DMK

Invesco’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Invesco’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-152
Closed -$24K – 3857
2018
Q4 		$24K Sell
152
-13
-8% -$2.49K ﹤0.01% 3752
2018
Q3 		$40K Buy
+165
New +$39.1K ﹤0.01% 3826

Other funds holding DMK

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Invesco's DMK Position: Q1 2019 in Review

Invesco sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2019, closing a stake of 152 shares — an estimated $24K sold.

Invesco first reported a position in DMK in Q3 2018 and held it in 2 quarters. The position peaked at $40K in Q3 2018. 57 funds tracked by Wall St. Rank hold DMK as of Q1 2019.

  • Invesco reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 152 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2019, an estimated $24K.
  • Invesco first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2018 and held it in 2 quarters.
  • Invesco's DMK Pharmaceuticals Corporation Common Stock position peaked at $40K in Q3 2018.
  • 57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.